XML 66 R41.htm IDEA: XBRL DOCUMENT v3.25.4

Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Valuation Assumptions

The relevant data used to determine the value of the stock options is as follows:

															December 31,
															2025						2024						2023 (1)
Weighted-average risk-free interest rate															1.63%						1.89%						N/A
Expected term in years															6.1						6.1						N/A
Weighted-average expected volatility															48.5%						49.5%						N/A
Expected dividends															0%						0%						N/A

(1) There were no stock options granted during 2023.

Schedule of Stock Option Activity

A summary of stock option activity for the year ended December 31, 2025 is as follows:

			Number of Options						Weighted-Average Exercise Price						Weighted-Average Remaining Contractual Term in Years						Aggregate Intrinsic Value
			(in thousands except for exercise price and term in years)
Outstanding balance at January 1, 2025			14,488						$	10.17					4.97						$	19,294
Granted			1,508						9.97
Exercised			(954)						9.10
Cancelled			(1,564)						14.34
Outstanding balance at December 31, 2025			13,478						$	10.05					5.07						$	27,659
Exercisable at December 31, 2025			10,095						$	9.98					4.52						$	25,311

Schedule of Restricted Stock Awards Activity

The summary of time vesting restricted stock units activity for the year ended December 31, 2025 is as follows:

			Number of Units						Weighted-Average Grant Date Fair Value
			(in thousands except for fair value)
Unvested, restricted stock units at January 1, 2025			3,901						$	10.18
Granted			3,684						9.92
Vested			(1,955)						10.30
Forfeited			(1,040)						9.86
Unvested, restricted stock units at December 31, 2025			4,590						$	10.00

Schedule of Stock-based Compensation Expense

Stock-based compensation expense was classified in the accompanying consolidated statements of operations and comprehensive income (loss) as follows:

			Year Ended December 31,
			2025						2024						2023
			(in thousands)
Cost of revenues			$	345					$	387					$	367
Sales and marketing			1,656						1,163						1,634
Product development			2,480						1,939						2,194
General and administrative			23,448						22,241						20,796
Total stock-based compensation expense			$	27,929					$	25,730					$	24,991

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested restricted stock shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Subparagraph (c)
-Paragraph 2
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration